The application scenarios of ivermectin continue to expand, and market development opportunities and challenges coexist

Ivermectin was discovered in the 1970s. With in-depth research, Ivermectin has been gradually used in aquaculture, agriculture, animal husbandry, medical treatment, pet drugs, and human health due to its good antibacterial and antiviral properties. and other fields. In 2022, foreign epidemic control was gradually relaxed, and there was a large outbreak of COVID-19 infections. The market demand for COVID-19 drugs was strong. The U.S. government official website recommended ivermectin for COVID-19 treatment, which further drove the rapid growth of ivermectin market demand.

Ivermectin is a macrolide antibiotic with a sixteen-membered ring. It appears as a white crystalline powder, is insoluble in water, and is easily soluble in solvents such as methanol, ethanol, acetone, and ethyl acetate. Ivermectin is a derivative of avermectin. It has the characteristics of high efficiency, broad spectrum, and low toxicity. It can be used to kill nematodes, arthropods and other parasites in and outside cattle, sheep, horses, pigs and other livestock. As a broad-spectrum antibacterial drug, ivermectin can also be used to treat respiratory tract infections, genitourinary system infections, and gastrointestinal tract infections.

According to the “2023-2028 Ivermectin Industry Market In-depth Research and Investment Prospect Forecast Analysis Report released by the Industrial Research Center , the current patent of ivermectin has expired and the formula has been disclosed, which means that the safety and effectiveness of the drug have been verified. Ivermectin manufacturers include Merck of the United States, North China Pharmaceuticals, East China Pharmaceuticals, Hebei North America Pharmaceuticals, Shandong Qifa Pharmaceuticals, Ningxia Taiyixin Biotech, Weiyuan Pharmaceuticals, etc.

Ivermectin dosage forms are divided into capsules, tablets, injections, etc. The production processes and quality standards of different dosage forms are also different. Ivermectin has high fermentation process requirements and high production costs, resulting in high product prices. In recent years, in order to accelerate the development of the ivermectin market, domestic and foreign companies have increased investment in ivermectin research and development and actively developed advanced production processes. and safe and efficient new ivermectin drugs. Against this background, the ivermectin industry is gradually developing towards high performance, low cost, high production efficiency and high quality.

As an antibiotic, ivermectin also has shortcomings such as drug resistance and drug side effects. In order to improve the anthelmintic effect and broaden the scope of anthelmintic, ivermectin compound products have attracted market attention. At present, common compound products of ivermectin include ivermectin + albendazole, ivermectin + fenflufenate, fenbenzofen + ivermectin, etc. Ivermectin is one of the most widely used ingredients in anthelmintic drugs. With the development of compound products, the application scenarios of ivermectin will be further expanded.

Industry analysts said that ivermectin has the characteristics of high efficiency, broad spectrum, low toxicity, etc., and is widely used in animal husbandry, aquaculture, It is widely used in pet medicine, medical and other fields. With the development of downstream markets, the application demand of ivermectin will be further released. However, as an antibiotic, in the context of anti-ban, the ivermectin market development opportunities and challenges coexist. Relevant companies should strengthen technological innovation, reduce costs, pay close attention to changes in policies and regulations, and make timely adjustments.